Skip to main content
Erschienen in: Clinical Rheumatology 9/2007

01.09.2007 | Review Article

The development of systemic sclerosis classification criteria

verfasst von: Jennifer G. Walker, Janet Pope, Murray Baron, Sharon LeClercq, Marie Hudson, Suzanne Taillefer, Steven M. Edworthy, Oleg Nadashkevich, Marvin J. Fritzler

Erschienen in: Clinical Rheumatology | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread.
Literatur
1.
Zurück zum Zitat Tan FK (2003) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237PubMedCrossRef Tan FK (2003) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237PubMedCrossRef
2.
Zurück zum Zitat Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005) New therapeutic strategies for systemic sclerosis—a critical analysis of the literature. Clin Dev Immunol 12(3):165–173PubMedCrossRef Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005) New therapeutic strategies for systemic sclerosis—a critical analysis of the literature. Clin Dev Immunol 12(3):165–173PubMedCrossRef
3.
Zurück zum Zitat Mayes MD, Giannini EH, Pachman LM et al (1997) Connective tissue disease registries. Arthritis Rheum 40:1556–1559PubMedCrossRef Mayes MD, Giannini EH, Pachman LM et al (1997) Connective tissue disease registries. Arthritis Rheum 40:1556–1559PubMedCrossRef
4.
Zurück zum Zitat Barnett AJ, Miller MH, Littlejohn GO (1988) A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15(2):276–283 (Feb)PubMed Barnett AJ, Miller MH, Littlejohn GO (1988) A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15(2):276–283 (Feb)PubMed
5.
Zurück zum Zitat Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13 (Jan–Feb)PubMed Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13 (Jan–Feb)PubMed
6.
Zurück zum Zitat Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Allegheny county, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 40(3):441–445PubMedCrossRef Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Allegheny county, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 40(3):441–445PubMedCrossRef
7.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
8.
Zurück zum Zitat Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590CrossRef
9.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205 (Feb)PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205 (Feb)PubMed
10.
Zurück zum Zitat Nadashkevich N, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621PubMed Nadashkevich N, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621PubMed
11.
Zurück zum Zitat Fries JF, Hochberg MC, Medsger TA Jr et al (1994) Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 37(4):454–462PubMedCrossRef Fries JF, Hochberg MC, Medsger TA Jr et al (1994) Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 37(4):454–462PubMedCrossRef
12.
Zurück zum Zitat Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Arthritis Rheum 52(4):1000–1008PubMedCrossRef Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Arthritis Rheum 52(4):1000–1008PubMedCrossRef
13.
Zurück zum Zitat Classification and response criteria subcommittee of the American College of Rheumatology Committee on Quality Measures (2006) Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (Arthritis Care and Research) 55(3):348–352CrossRef Classification and response criteria subcommittee of the American College of Rheumatology Committee on Quality Measures (2006) Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (Arthritis Care and Research) 55(3):348–352CrossRef
14.
Zurück zum Zitat Felson DT, Anderson JJ (1995) Methodological and statistical approaches to criteria development in rheumatic diseases. Bailliere’s Clin Rheumatol 9:253–266CrossRef Felson DT, Anderson JJ (1995) Methodological and statistical approaches to criteria development in rheumatic diseases. Bailliere’s Clin Rheumatol 9:253–266CrossRef
15.
Zurück zum Zitat Maricq HR, Weinrich MC, Keil JE et al (1989) Prevalence of the scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006PubMedCrossRef Maricq HR, Weinrich MC, Keil JE et al (1989) Prevalence of the scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006PubMedCrossRef
16.
Zurück zum Zitat Steen V, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444PubMedCrossRef Steen V, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444PubMedCrossRef
17.
Zurück zum Zitat Steen V, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835PubMedCrossRef Steen V, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835PubMedCrossRef
18.
Zurück zum Zitat Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916PubMed Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916PubMed
19.
Zurück zum Zitat Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81(2):139–153CrossRef Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81(2):139–153CrossRef
20.
Zurück zum Zitat Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81(2):154–167CrossRef Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81(2):154–167CrossRef
21.
Zurück zum Zitat Tuffanelli DL, Winkelmann RK (1962) Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 57:198–203PubMed Tuffanelli DL, Winkelmann RK (1962) Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 57:198–203PubMed
22.
Zurück zum Zitat Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15(6):894–898 (Jun)PubMed Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15(6):894–898 (Jun)PubMed
23.
Zurück zum Zitat Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755PubMedCrossRef Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755PubMedCrossRef
24.
Zurück zum Zitat Reveille JD, Solomon DH, The American College of Rheumatology Ad hoc Committee on Immunologic Testing Guidelines (2003) Evidence-based guidelines for the use of immunologic tests: anticentromere, Sl–70 and nucleolar antibodies. Arthritis Rheum 49(3):399–412PubMedCrossRef Reveille JD, Solomon DH, The American College of Rheumatology Ad hoc Committee on Immunologic Testing Guidelines (2003) Evidence-based guidelines for the use of immunologic tests: anticentromere, Sl–70 and nucleolar antibodies. Arthritis Rheum 49(3):399–412PubMedCrossRef
25.
Zurück zum Zitat Arnett F, Reveille JD, Goldstein R et al (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serological and clinical analysis. Arthritis Rheum 39:1151–1160PubMedCrossRef Arnett F, Reveille JD, Goldstein R et al (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serological and clinical analysis. Arthritis Rheum 39:1151–1160PubMedCrossRef
26.
Zurück zum Zitat Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:1212–1216CrossRef Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:1212–1216CrossRef
27.
Zurück zum Zitat Cepeda EJ, Reveille JD (2004) Antibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732PubMedCrossRef Cepeda EJ, Reveille JD (2004) Antibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732PubMedCrossRef
28.
Zurück zum Zitat Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427PubMedCrossRef Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427PubMedCrossRef
29.
Zurück zum Zitat Steen VD, Powell DL (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef Steen VD, Powell DL (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef
30.
Zurück zum Zitat Bernstein RM, Steigerwald JC, Tan EM (1982) Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 48(1):43–51 Bernstein RM, Steigerwald JC, Tan EM (1982) Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 48(1):43–51
31.
Zurück zum Zitat Satiago M, Baron M, Burlingame RW et al (2007) Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA. Arthritis Rheum (Arthritis Care and Research) (submitted for publication, January 2007) Satiago M, Baron M, Burlingame RW et al (2007) Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA. Arthritis Rheum (Arthritis Care and Research) (submitted for publication, January 2007)
32.
Zurück zum Zitat Tormey VJ, Bunn CC, Denton CP et al (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford) 40(10):1157–1162CrossRef Tormey VJ, Bunn CC, Denton CP et al (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford) 40(10):1157–1162CrossRef
33.
Zurück zum Zitat Brown GE, O’Leary PA (1925) Skin capillaries in scleroderma. Arch Intern Med 36:73–88 Brown GE, O’Leary PA (1925) Skin capillaries in scleroderma. Arch Intern Med 36:73–88
34.
Zurück zum Zitat Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628PubMedCrossRef Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628PubMedCrossRef
35.
Zurück zum Zitat Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19(3):437–452PubMedCrossRef Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19(3):437–452PubMedCrossRef
36.
Zurück zum Zitat Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24(9):1159–1165PubMedCrossRef Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24(9):1159–1165PubMedCrossRef
37.
Zurück zum Zitat Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
38.
Zurück zum Zitat Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connectiv tissue disease ad Raynaud’s diseases. J Eur Dermatol Acad Venereol 18:62–68CrossRef Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connectiv tissue disease ad Raynaud’s diseases. J Eur Dermatol Acad Venereol 18:62–68CrossRef
39.
Zurück zum Zitat Cutolo M, Pizzorni C, Tuccio A et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726CrossRef Cutolo M, Pizzorni C, Tuccio A et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726CrossRef
40.
Zurück zum Zitat Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy—a new tool for assessment of Rayaud’s phenomenon. J Rheumatol 32:841–848PubMed Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy—a new tool for assessment of Rayaud’s phenomenon. J Rheumatol 32:841–848PubMed
41.
Zurück zum Zitat Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030PubMedCrossRef Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030PubMedCrossRef
42.
Zurück zum Zitat Baron M, Bell M, Bookman A et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheum (in press) Baron M, Bell M, Bookman A et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheum (in press)
43.
Zurück zum Zitat Capusan I (1972) Curzio’s case of scleroderma (letter). Ann Intern Med 76(1):146PubMed Capusan I (1972) Curzio’s case of scleroderma (letter). Ann Intern Med 76(1):146PubMed
44.
Zurück zum Zitat Barnett AJ (1978) Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 patients. Med J Aust 2(4):129–134PubMed Barnett AJ (1978) Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 patients. Med J Aust 2(4):129–134PubMed
45.
Zurück zum Zitat Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140PubMedCrossRef Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140PubMedCrossRef
46.
Zurück zum Zitat Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286PubMedCrossRef Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286PubMedCrossRef
47.
Zurück zum Zitat Vayssairat M, Baudot N, Abuaf N et al (1992) Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheum 11(3):356–363CrossRef Vayssairat M, Baudot N, Abuaf N et al (1992) Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheum 11(3):356–363CrossRef
48.
Zurück zum Zitat Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736 (Mar)PubMedCrossRef Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736 (Mar)PubMedCrossRef
Metadaten
Titel
The development of systemic sclerosis classification criteria
verfasst von
Jennifer G. Walker
Janet Pope
Murray Baron
Sharon LeClercq
Marie Hudson
Suzanne Taillefer
Steven M. Edworthy
Oleg Nadashkevich
Marvin J. Fritzler
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 9/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0537-x

Weitere Artikel der Ausgabe 9/2007

Clinical Rheumatology 9/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.